Related Experiment Video
Updated: Jun 4, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
Development of vaccines against tuberculosis
Anil K Tyagi1, Prachi Nangpal, Vijaya Satchidanandam
1Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, New Delhi 110021, India. aniltyagi@south.du.ac.in
Developing an effective tuberculosis (TB) vaccine requires understanding Mycobacterium tuberculosis immune responses. Indian scientists are advancing TB vaccine development through new antigen discovery and evaluation in animal models.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Effective tuberculosis (TB) vaccine development is crucial and relies on understanding human immune responses to Mycobacterium tuberculosis.
- Current strategies aim to stimulate specific immune responses and generate memory cells for long-term protection.
- The urgent need for a TB vaccine drives the development and clinical trial progression of promising candidates.
Purpose of the Study:
- To review the contributions of Indian scientists in TB vaccine development.
- To highlight advancements in the discovery of new TB antigens.
- To summarize research on immune responses to TB antigens and the evaluation of novel vaccines in preclinical models.
Main Methods:
- Literature review focusing on Indian scientific contributions to TB vaccine research.
- Analysis of studies on antigen discovery for Mycobacterium tuberculosis.
- Examination of research on immune responses and vaccine efficacy in animal models.
Main Results:
- Indian scientists have made significant contributions to TB vaccine research, including novel antigen identification.
- Studies have elucidated immune responses elicited by various antigens against TB.
- Several new TB vaccine candidates have been developed and evaluated in animal models.
Conclusions:
- Indian research plays a vital role in advancing TB vaccine development.
- Continued focus on antigen discovery and immune response characterization is essential.
- Preclinical evaluation in animal models is key to progressing TB vaccine candidates.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microorganisms in Medicine and Therapeutics

